Skip to the page

Data / Form D filings / LifeBridge Innovations, PBC

LifeBridge Innovations, PBC: Form D filings

LifeBridge Innovations, PBC, a biotechnology company in Longwood, FL, filed 8 Form D notices with the SEC between 2017 and 2026. The latest, on July 14, 2026, reports $3.4 million sold of a $5 million offering to 64 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
862 E. WILDMERE AVENUE, Longwood, FL, 32750
Phone
(407) 416-1099
Industry
Biotechnology
Entity type
Other
Incorporated in
Delaware
Year incorporated
2022
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(c)
SEC identifier (CIK)
1696893

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jul 14, 2026Amendment$5,000,000$3,375,500$1,624,50064Jun 24, 2025sec.gov
Jul 8, 2025New notice$5,000,000$215,000$4,785,0006Jun 24, 2025sec.gov
May 7, 2025New notice$1,000,000$0$1,000,0000Apr 23, 2025sec.gov
Jul 12, 2022New notice$4,025,000$45,400$3,979,6003Jun 7, 2022sec.gov
Jun 8, 2018Amendment$3,600,000$0$3,600,00011May 23, 2018sec.gov
Jun 6, 2018Amendment$3,600,000$0$3,600,00011Yet to occursec.gov
Mar 30, 2018Amendment$3,600,000$0$3,600,0000Yet to occursec.gov
Feb 2, 2017New notice$3,600,000$0$3,600,0000Yet to occursec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Peter TraversExecutive Officer, Director, Promoter
Yung-Ping YehDirector
Jim LaBateDirector
Mike BlackExecutive Officer

Other biotechnology companies in Florida that filed recently

Every Form D from the week of Jul 13, 2026 · All recent filings in Florida · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what LifeBridge Innovations, PBC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.